GSK plc (GSK)

NYQ – Real Time Price. Currency in USD

50.27

-0.63 (-1.24%)

Market open: Aug 12, 2026, 12:50 PM EDT

51.62

+0.72 (1.41%)

Previous after-hours: Aug 11, 2026, 7:53 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

43.05B

40.09B

37.70B

36.12B

Cost of goods sold

-12.29B

-12.11B

-11.28B

-12.15B

Gross Profit

30.76B

27.98B

26.42B

23.97B

Operating expenses (excl. COGS)

-19.93B

-20.75B

-17.72B

-15.74B

Operating Income

10.83B

7.23B

8.69B

8.23B

Non-operating income, total

-1.08B

-2.79B

-1.15B

-1.30B

Pretax income

9.75B

4.45B

7.54B

6.93B

Equity in earnings

-4M

-6M

-2M

Taxes

-1.47B

-672M

-940M

-871M

Non-controlling/minority interest

-755M

-480M

-472M

-567M

After tax other income/expense

Net income before discontinued operations

7.53B

3.29B

6.13B

5.49B

Discontinued operations

12.93B

Net income

7.53B

3.29B

6.13B

18.42B

Dilution adjustment

Preferred dividends

GSK plc (GSK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

GSK plc (GSK)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

GSK plc (GSK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

GSK plc (GSK)

Income Statement (Annual)

Income Statement (Annual)